Javelin Presents PMI-150 (Intranasal Ketamine For Acute Pain) Data At Premier Department Of Defense Scientific Meeting Javelin Pharmaceuticals, Inc. (AMEX:JAV), a leading developer of novel products for pain management, is presenting data today on its PMI-150 drug candidate (intranasal ketamine for acute pain) at the Department of Defense's (DoD) 2008 Advanced Technology Applications for Combat Casualty Care (ATACCC) Conference.
Source: www.medicalnewstoday.com
# posted by Network @ 5:00 AM
